Gastroenteropancreatic Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Gastroenteropancreatic Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver [EARLY_Phase 1]
This clinical trial update describes an early-phase study of Lutathera in people with gastroenteropancreatic, bronchial, or unknown primary …
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET) [Phase 2]
Phase 2 clinical trial evaluating the efficacy, safety, and pharmacokinetics of subcutaneous octreotide in patients with gastroenteropancrea…
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM) [Phase 2]
Phase 2 clinical trial evaluating the activity and safety of combining cabozantinib with temozolomide in lung and gastroenteropancreatic neu…
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients [Phase 4]
This Phase 4 trial update describes continuing somatostatin analogue therapy in patients with gastroenteropancreatic neuroendocrine tumors a…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Observational Study on GEP-and Pulm-NET Treated at FPG
An observational clinical trial update describes a study of gastroenteropancreatic and pulmonary neuroendocrine tumors treated at Fondazione…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Surgical Intervention and the NETest [NA]
Clinical trial update for a surgical intervention study using the NETest in neuroendocrine tumors. Sponsor Wren Laboratories LLC indicates t…